The “Global In-Vitro Diagnostics (IVD) Market by Product & Service (Instruments, Kits, Software), Technology (Immunoassay, Hematology, Urinalysis),…
Category: Insights
Global Market for Advanced Antimicrobial Coatings and Technologies 2023-2033: Increased Awareness of Bacteria and Infections Brought on by COVID-19 Boosts Growth
The “The Global Market for Advanced Antimicrobial Coatings and Technologies 2023-2033” report has been added to ResearchAndMarkets.com’s offering. The use…
Astellas Announces Hold Lifted by FDA on FORTIS Clinical Trial of AT845 Investigational Treatment for Adult Patients with Late-Onset Pompe Disease
Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) today announced that the U.S.…
Castor Oil-Based Biopolymer Global Market Report 2022: Sector to Reach $3.32 Billion by 2031 at a 16.7% CAGR
The “Castor Oil-Based Biopolymer Market – A Global and Regional Analysis: Focus on End User, Polymer Type,…
Cardiovascular catheters market size to increase by USD 6.97 billion: Asia will account for 39% of the market’s growth during the forecast period – Technavio
The Cardiovascular Catheters Market by Product, End-user, and Geography – Forecast and Analysis 2023-2027 report has been published…
Electronic health records market 2023-2027: A descriptive analysis of parent market, five forces model, market dynamics, and segmentation – Technavio
According to Technavio, the global electronic health records market size is estimated to grow by USD 32.27 billion from 2022 to…
China welcomes first arrivals following downgraded COVID management
A report from People’s Daily: The first flights under China’s new COVID-19 management for international travelers arrived at…
Low-Carb Diet Market to Perceive Remarkable Growth of 18.65 Billion by 2029, Size, Share, Trends, Demand, Opportunities, Challenges and Revenue Analysis
Data Bridge Market Research has recently published a Report, titled, “Low-Carb Diet Market” The report offers an…
Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2022 Financial Results and Provides Business Update
$41.7 million in cash and cash equivalents as of September 30, 2022; extends runway through December 2023 Mino-Lok® Phase…
Asep Medical Holdings Inc. Achieves Significant Milestones Addressing Antibiotic Failure Through Proprietary Diagnostic & Therapeutic Technologies
Asep Medical Holdings Inc. (“Asep Inc.” or the “Company”) (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is pleased to announce that, through…